P. Vogt

Molecular Biology · 2005–2008

A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 3 researchers here, as inferred from the citation graph.

Subfields

Whom P. Vogt trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Lewis C. Cantley (in Molecular Biology)

Who trusts P. Vogt

  1. J. Engelman (in Molecular Biology)
  2. Arkaitz Carracedo (in Molecular Biology)
  3. P. Pandolfi (in Molecular Biology)

Papers from P. Vogt's perspective

Ordered by how strongly the researchers P. Vogt trusts endorse each paper. Same corpus, a different order for every researcher.

  1. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. (Cell)
  2. Upstream and downstream of mTOR. (Genes & Development)
  3. The Mammalian Target of Rapamycin (mTOR) Partner, Raptor, Binds the mTOR Substrates p70 S6 Kinase and 4E-BP1 through Their TOR Signaling (TOS) Motif* (Journal of Biological Chemistry)
  4. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. (Cell)
  5. A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus (Proceedings of the National Academy of Sciences of the United States of America)
  6. Erlotinib in lung cancer - molecular and clinical predictors of outcome. (New England Journal of Medicine)
  7. Anticancer drugs: To the rescue? (Nature reviews. Drug discovery)
  8. Nuclear factor-κB inhibitors as sensitizers to anticancer drugs (Nature Reviews. Cancer)
  9. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR (Proceedings of the National Academy of Sciences of the United States of America)
  10. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling (Nature Cell Biology)

Their papers